Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...

Diabetic kidney disease affects a growing proportion of people with diabetes and remains the leading cause of end-stage renal ...

Cancer researchers have long treated genetic chaos and epigenetic rewiring as separate engines of disease, two parallel ...

Oncology and tackling chronic issues like obesity are still the big drivers for growth in the biotech world. Combining ...

Lung-on-chip model made of cells derived from a single person furthers understanding of tuberculosis and potential ...

Cellarity, a clinical-stage biotechnology company developing Cell State-Correcting therapies through integrated multi-omics and AI modeling, today announced that Chief Executive Officer Ted Myles will ...

Immune checkpoint molecules play a crucial role in keeping the immune system in balance and preventing an attack on the ...

Researchers at the Francis Crick Institute and AlveoliX have developed the first human lung-on-chip model using stem cells ...

Researchers at the Francis Crick Institute and AlveoliX have developed the first human 'lung-on-chip' model using stem cells ...

A new method for engineering natural killer cells could make cancer immunotherapy more efficient, scalable, and affordable, ...

The chip can simulate breathing and lung disease for an individual, holding promise for testing personalized treatments for tuberculosis.